Official Journal of Research Center for Gastroenterology and Liver Diseases
Liver Hemangioma Might Lead to overestimation of Liver Fibrosis by Fibroscan; A Missed Issue in Two Cases
Authors
Abstract
Background: The assessment of liver fibrosis is an important way for prediction of liver disease progression and patient’s prognosis. Liver stiffness measurement (LSM) is strongly associated with stage of liver diseases. Overestimation of liver fibrosis in heart failure has been reported. We would like to introduce a new leading cause of liver fibrosis overestimation by presentation of two cases.
Case Presentation: One case with right lobe hemangioma has an overestimation of liver fibrosis. The result completely changed when Fibroscan was performed in patient’s left lobe. Interestingly, another case with left lobe hemangioma had overestimation of fibrosis in her left lobe but, right lob Fibroscan was normal.
Conclusions: We found that liver hemangioma may leads to overestimation of liver stiffness and the correct inspection of liver echogenicity before any interpretation of high liver stiffness is recommended. We suggest that patient with higher level of Fibroscan score repeat it in other sides of the liver. Also, they should be evaluated by sonography for ruling out of possible confounders such as hepatic hemangioma.
Implication for health policy/practice/research/medical education:
Hemangioma is a benign, asymptomatic, and suddenly founded hepatic tumor. Prevalence of hemangioma is high in general population.The correct inspection of liver echogenicity before any interpretation of high liver stiffness is recommended.
Please cite this paper as:
Aalaei Andabili SH, Mehrnoush L, Salimi S, Shafiei M, Alavian SM. Liver Hemangioma Might Lead to overestimation of Liver Fibrosis by Fibroscan; A Missed Issue in Two Cases. Hepat Mon. 2012;12(6): 408-410. DoI: 10.5812/hepatmon.6685
Copyright © 2012 Kowsar Corp. All rights reserved.
Copyright
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy
Malekzadeh R, Poustchi H. Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy. Hepat Mon. 2011;11(3):. doi:
Embolization of Liver Hemangiomas
Kayaalp C, Sabuncuoglu MZ. Embolization of Liver Hemangiomas. Hepat Mon. 2015;15(8):e30334. doi: https://doi.org/10.5812/hepatmon.30334
Two or More Synchronous Combination of Noninvasive Test to Increase Accuracy of Liver Fibrosis in Chronic Hepatitis C
Testa R. Two or More Synchronous Combination of Noninvasive Test to Increase Accuracy of Liver Fibrosis in Chronic Hepatitis C. Hepat Mon. 2012;12(5):. doi: https://doi.org/10.5812/hepatmon.6229
Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis C
Ladero J, Ladero J. Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis C. Hepat Mon. 2011;11(9):. doi: https://doi.org/10.5812/kowsar.1735143X.738
Noninvasive Methods to Evaluate Liver Fibrosis in Chronic HCV Infection
El-Shabrawi M, Isa M. Noninvasive Methods to Evaluate Liver Fibrosis in Chronic HCV Infection. Hepat Mon. 2011;11(9):. doi: https://doi.org/10.5812/kowsar.1735143X.711
- Scopus by DOI: 4
Last Update: 3 weeks ago
- Scopus by Title: 4
Last Update: 3 weeks ago
- Scopus by Title (Ref): 4
Last Update: 3 weeks ago
- CrossRef: 3
Last Update: 1 day ago